Virulence of Escherichia coli Clinical Isolates in a Murine
. To supplement these generic clinical isolates, a set of 12 urine and blood isolates representing 9 classic ExPEC clonal groups, 1 to 3 representatives per clonal group, was assembled from the investigator's collection (29) (Table 1) . Included were 8 strains from phylogenetic group B2, representing 5 different clonal groups, i.e., CC12 (O4:Kϩ:H5/HϪ) (31), ST73 (O6:K2:H1) (18), ST81 (O75:K5:HϪ) (9), ST95 (O18:K1:H7) (14) , and ST127 (O6:K15:H31) (18) , and 4 strains from phylogenetic group D, representing 4 different clonal groups, i.e., ST59 (O1:K1:HϪ) (1), ST62 (O7:K1:HϪ) (1), ST69 (also known as "clonal group A"; O17:K52:H18) (24) , and ST598/CC31 (O15:K52:H1) (39) . The specific clinical syndromes represented by these strains included cystitis, pyelonephritis, urosepsis, and neonatal meningitis (Table 1) .
Finally, 5 FQ-resistant (ϩ/Ϫ ESBL positive) ST131 isolates that had been the subject of case reports because of their distinctive clinical behavior and seeming within-household transmission were also studied (8, 11, 40) (Table 1 ). All represented pulsotype 968, the predominant pulsotype among recent ST131 isolates in the United States (27) . Of the 5 isolates, 4 were paired isolates from epidemiologically associated adults (a fatherdaughter pair and 2 sisters) from 2 different families in widely separated locales (8, 40) . Within each such isolate pair, one isolate had caused a mild-to-moderately severe infection in one family member, whereas the other had caused a severe or fatal infection in a different family member. The fifth ST131 case report isolate was from a 4-month-old girl with protracted septic arthritis and contiguous osteomyelitis (11) . This strain likewise was identified in another household member (the patient's mother), as a fecal colonizer, which was not studied here. Mouse sepsis model. Isolates were tested for extraintestinal virulence using an established mouse model of systemic sepsis (13, 42) . Approximately 10 8 CFU of log-phase organisms (from shaking broth cultures), suspended in saline, were injected subcutaneously into the nape of the neck of female Swiss-Webster mice (mean weight, 23 g; range, 20 to 30 g). Mice were observed twice daily over the following 3 days for health status, which was scored on a 5-step scale (1 ϭ healthy, 2 ϭ minimally ill, 3 ϭ moderately ill, 4 ϭ severely ill, 5 ϭ dead), with the worst score on a given day being used as the score for that day. Mice were euthanatized if observed in stage 4 illness or at the end of the 72-h observation period, whichever came first. Mice euthanatized on day 1 or 2 received a score of 5 for the subsequent day(s). The mean of the three daily health status scores was used to summarize quantitatively each mouse's infection experience over the 3-day observation period. In addition, mice were scored as "dead" or "alive," with any daily status score of 4 or 5 qualifying as "dead," since in pilot experiments all mice that reached stage 4 illness died spontaneously either later that day or overnight (not shown).
For each isolate, two main outcome measures were assigned. The lethality score was the proportion of mice challenged with the isolate (0 to 1.0) that died within 3 days postinoculation, whereas the median mouse mean status score (1.0 to 5.0) was the group median for mouse mean status for all mice inoculated with the isolate. Additionally, isolates were classified as rapidly lethal if Ն50% of mice challenged with them died within 24 h postinjection, which corresponds with a median mean status score of 5.0.
On each day of mouse injections, the test isolates included an equal number of representatives of each of the 4 matched isolate groups (groups 1 to 4), ϩ/Ϫ classic ExPEC strains or case report ST131 isolates (groups 5 to 6). Test isolates were administered to 5 mice each, in random sequence. In parallel, 5 mice each also received strains CFT073 (positive control) (32) and E. coli K-12 derivative MG1655 (negative control) (3). Test isolates that exhibited disproportionate variability of effect (i.e., standard error [SE] Ͼ 0.20 for mouse mean status) among the first 5 mice challenged were tested subsequently in 5 additional mice, and these results were then pooled with those from the initial 5 mice.
To confirm specificity of effect, in pilot experiments, postmortem quantitative cultures of cardiac puncture blood and spleen homogenates were done at the time of euthanasia or for mice found dead. Consistently, healthy mice had sterile or very low-count cultures, whereas cultures from ill mice were uniformly positive and yielded heavier growth, with bacterial densities correlating significantly with clinical severity (not shown). Likewise, for each of several dozen mice challenged with various isolates, postmortem spleen and blood isolates matched the corresponding challenge isolate according to random amplified polymorphic DNA profiling (2), whereas the different challenge isolates exhibited distinctive profiles (not shown).
Virulence genotyping and phylotyping. Isolates were characterized for 43 virulence-associated genes and variants thereof by using established multiplex PCR-based assays (Table 2) (23) . Major E. coli phylogenetic group was assessed by triplex PCR, using the initially described interpretive criteria (4). Testing was done in duplicate, using as template DNA boiled lysates prepared separately from two different colonies of each isolate. The virulence score was the number of virulence markers detected, adjusted for multiple detection of the pap (P fimbriae), sfa/foc (S and F1C fimbriae), and kps II (group 2 capsule) operons. The molecular criterion for ExPEC was detection of Ն2 of the following 5 markers: papA and/or papC (P fimbria structural subunit and assembly; counted as 1), sfa/focDE, afa/draBC (Dr-binding adhesins), kpsM II, and iutA (aerobactin system) (26) .
Statistical analysis.
Comparisons of proportions were tested using Fisher's exact test (two-tailed). Comparisons of virulence scores, percent mouse lethality, and mean mouse status were tested using the MannWhitney U test or the Kruskal-Wallis test for nonnormally distributed data, and a two-tailed t test or analysis of variance (ANOVA) for normally distributed data. In some comparisons, to account for clustering by isolate and isolate group, a generalized estimating equation model was used, with mice clustered by isolate and nested within isolate group (the betweensubject grouping variable at the next higher hierarchical level). The criterion for statistical significance was a P value of Ͻ0.05.
RESULTS
Performance of the sepsis model. In the mouse sepsis model, within each week's experiment, a median of all 5 mice challenged with positive-control strain CFT703 became moribund or died, compared with none of 5 mice challenged with negative-control strain MG1655, which uniformly remained completely healthy appearing. This excluded important week-to-week or within-experiment variation in the sepsis model.
With the 61 test clinical isolates, sepsis model outcomes were fairly consistent among the mice challenged with a given isolate. However, 16 isolates (26%) required repeat testing due to excessive initial mouse-to-mouse variability.
In contrast to the general consistency of effect observed for individual isolates, outcomes varied dramatically among isolates. That is, the different test isolates exhibited a wide range of experimental virulence, ranging from universal lethality (n ϭ 21 isolates) and even rapid lethality (i.e., Ն50% of mice dead within 24 h of inoculation; n ϭ 6), to no lethality (n ϭ 18) and even no evident effect whatsoever (n ϭ 3), comparable to negative-control strain MG1655 (Fig. 1) .
Experimental outcomes versus isolate group, ST131 status, and FQ phenotype. Comparisons for percent mouse lethality and mean mouse status were made initially among the 6 prespecified isolate groups, which included 4 temporally and geographically matched sets of generic clinical isolates representing the 4 possible combinations of ST131 status and FQ phenotype (n ϭ 11 isolates each), representatives of 9 classic ExPEC clonal groups (n ϭ 12 isolates), and household transmission case report ST131 isolates (n ϭ 5 isolates). Although the median values varied somewhat by isolate group for both main outcome measures, i.e., percent lethality and mean mouse status, within-group variation was extremely high, with one or more isolates from each group occupying either extreme of the scale (Fig. 1) . Accordingly, the 6 groups did not differ significantly from one another for either outcome measure (P Ͼ 0.10), whether this was assessed using the generalized estimating equation (to account for clustering of mice by isolate) or ANOVA (which regards each mouse as an independent observation). Likewise, although rapid lethality was somewhat more common among the classic ExPEC strains (4/12) than within any other study group (0 to 1 rapidly lethal isolate per group), these between-group differences were not statistically significant (not shown).
In contrast, for both main outcome measures, highly statistically significant differences were evident within each isolate group (Fig. 1) . This was true both for each group as a whole (Fig. 1 ) and for at least one (and usually multiple) possible pairwise comparisons between different group members (not shown). Additionally, differences in virulence were observed between members of certain non-ST131 clonal groups, e.g., within ST95 (where cystitis isolate NU14 appeared much less virulent than cystitis isolate U8 or neonatal meningitis isolate RS218) and CC12 (where urinary tract infection isolate IA2 appeared much less virulent than bacteremia isolate CP9) ( Table 1) .
Because of this apparent lack of association of isolate group or clonal group membership with infection outcomes, the 6 isolate groups were combined, allowing statistical comparisons according to ST131 status and FQ phenotype within the total population. Despite the increased statistical power from the larger sample size, neither ST131 status nor FQ phenotype was significantly associated with either percent lethality or mean mouse status, regardless of whether by-isolate clustering was taken into account in the analysis (not shown). Collectively, these analyses showed that although the mouse sepsis model clearly identified striking differences in virulence among the study isolates, these differences did not correspond with isolate group, ST131 status, or FQ phenotype.
Experimental outcomes versus virulence genotype and phylogenetic group. To identify alternate explanations for the observed virulence differences, we next compared virulence, as reflected in percent lethality and mouse mean status, with bacterial characteristics other than ST131 status and FQ phenotype. These included phylogenetic group, individual virulence genes, ExPEC status, and aggregate virulence score, for many of which characteristics the 6 isolate groups differed substantially (Tables 2 and 3) .
These comparisons identified significant associations of 7 individual virulence genes, plus the derived variable of molecularly inferred ExPEC status, with one or both virulence outcome variables (Table 4 ). The 7 outcome-associated virulence genes represented diverse functional categories, including adhesins (papAH, papG allele III) (15), toxins (vat) (7), protectins (kpsM II, K1 capsule) (28), invasins (ibeA) (10) , and miscellaneous traits (clbB/N) (19) . The two outcome measures (lethality, mean status) exhibited overlapping yet distinctive patterns of association with the 7 virulence genes, 5 of which were significantly associated with only one outcome measure or the other. Additionally, aggregate virulence score was significantly or borderline significantly associated 
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DISCUSSION
In this assessment of 61 ST131 and non-ST131 E. coli clinical isolates for extraintestinal virulence in a murine sepsis model, we found a broad range of virulence within the study population. In conflict with our prior hypothesis, neither ST131 status nor FQ phenotype was significantly associated with virulence. Moreover, each isolate group (as defined based on ST131 status and FQ phenotype, classic ExPEC clonal group status, or ST131 case report status) exhibited a broad range of virulence, evidence of pathogenic diversity within these isolate groups and against a direct link between virulence and the group-defining variables. In contrast, multiple putative or proven ExPEC virulence genes, plus molecularly defined ExPEC status, correlated significantly with virulence. These findings contradict the assumptions that ST131 isolates have a higher virulence potential than other E. coli isolates, that case report ST131 isolates are more virulent than other ST131 isolates, and that, irrespective of ST131 status, FQ-resistant E. coli isolates, per se are less virulent than FQ-susceptible E. coli isolates (49) . In contrast, they implicate accessory traits (e.g., virulence factors) as the primary determinants of extraintestinal virulence (13, 20) . They thus indicate a need to discover the presumed unidentified accessory traits that accounted for the observed withingroup variation, including the residual virulence differences that remain after accounting for known virulence genes.
Our findings can be compared with previous related work. The authors of one of the first reports of the ST131 clonal group observed that all 4 ST131 isolates they studied in the murine sepsis model yielded 100% lethality among the 10 mice challenged per isolate (5) . This seeming discrepancy with the present finding of considerable virulence diversity among ST131 isolates might be due to undefined differences in experimental conditions, use of different ST131 strains, or chance variation related to small numbers. Additionally, an earlier study that used the murine sepsis model to test a large number of clinical and fecal non-ST131 E. coli isolates found, in agreement with the present study, that specific accessory traits (virulence factors) were more predictive of lethality than were phylogenetic background or clinical source (13) . Differences between that and the present study regarding which specific accessory traits were predictive of lethality and whether group B2 status is associated with virulence likely relate to the very different study populations, since the present study included only clinical isolates and was heavily biased toward (group B2-derived) ST131.
Thus, the preponderance of experimental animal model evidence indicates that ST131 isolates are neither uniformly virulent nor, as a group, discernibly more virulent than other extraintestinal E. coli isolates. How can this conclusion be reconciled with ST131's strikingly rapid emergence and current dominance as an extraintestinal pathogen (16, 41, 44) ? One possibility is that the experimental models used to date, which involve direct parenteral inoculation of the test isolate into the host, bypass key earlier steps in pathogenesis at which ST131 excels. These include the transition from intestinal colonizer to invasive pathogen, with the corresponding requirement for adherence to vaginal and urinary epithelial cells, and entry into and persistence within normally sterile sites such as the urinary tract (47) . Alternatively (or additionally), ST131's striking epidemiological success may not be related to its pathogenic potential per se but rather to an enhanced ability to disseminate among hosts and/or to establish and maintain intestinal colonization upon encountering a new host. Both phenomena predictably would increase the number of hosts colonized with an ST131 strain, thereby increasing the likelihood of ST131 causing an infection, even if only by chance. This harkens back to the classic dichotomy between prevalence (within the intestinal microbiota) versus special pathogenicity as the underlying explanation for why certain E. coli genotypes tend to cause urinary tract infection (37) . In support of the enhanced dissemination hypothesis, abundant molecular epidemiological evidence indicates that ST131 strains move rapidly and extensively among locales, to a greater extent than non-ST131 E. coli (16, 27, 38, 41, 44) . In contrast, very little is known about the intestinal colonization dynamics of ST131 versus non-ST131 E. coli (11, 25, 33) , making this an area ripe for future investigation.
Another notable study finding was that the ST131 case report isolates, despite having caused serious or fatal disease in their respective source patients, were not demonstrably more virulent in the mouse sepsis model than were the generic ST131 clinical isolates, which in contrast were selected based strictly on their ST131 status, FQ phenotype, and date and locale of isolation. Presuming the experimental system used provides a valid indication of a strain's intrinsic virulence potential, this finding suggests that the case report source patients' severe outcomes (8, 11, 40) may have been more attributable to host or environmental factors, or to chance, than to bacterial factors. Also of interest was the seeming variation in virulence within each of the 2 pairs of presumably closely related (within-household-transmitted) ST131 isolates. Possible explanations for this, aside from experimental artifact, include subtle virulence-relevant genetic differences such as minor sequence variation in conserved genes (35, 50) and/or mosaicism for relevant accessory traits (40) .
Related to this, the observed variation in experimental virulence within both ST131 and certain other ExPEC clonal groups, i.e., ST95 (O18:K1:H7) and CC12 (O4:Kϩ:H5/HϪ), invites an investigation of the underlying mechanisms. Whole-genome comparisons could be used to identify genetic differences that correspond with the observed virulence differences between these otherwise highly similar strains (34, 35, 36, 43, 50 ). This could be followed by molecular epidemiological studies assessing the distribution of these sequences in relevant comparison populations (e.g., clinical versus fecal isolates or isolates from distinct clinical syndromes or host groups) (46) and direct experimental assessment of their role in pathogenesis (12) .
Study limitations include the possibly unrepresentative nature of the study population (with isolate selection focusing on source collections containing all 4 combinations of ST131 status and FQ phenotype), the mouse sepsis model's artificiality and possible unsuitability for mimicking the pathogenesis of ST131-related human infections, lack of attention to upstream colonization and transmission steps, and attention to only a subset of known/suspected extraintestinal virulence genes (30) . Study strengths include the comparatively large number of ST131 isolates and controls, use of matched sets of comparison ST131/non-ST131 and FQ-resistant versus FQ-susceptible isolates, randomization of mice and isolates to reduce experimental artifacts, assessment of multiple bacterial characteristics in relation to virulence, and use of advanced statistical methods that address clustering.
In summary, we utilized a mouse subcutaneous sepsis model to compare the virulence of a large number of ST131 and non-ST131 E. coli clinical isolates, both FQ resistant and susceptible, plus isolates from classic ExPEC clonal groups and case report E. coli ST131 household transmission isolates. Although the study isolates displayed considerable diversity of virulence behavior, neither ST131 status nor FQ phenotype corresponded with this diversity. In contrast, multiple known or suspected ExPEC virulence genes, and molecularly defined ExPEC status, were significantly associated with experimental virulence. These findings point away from ST131 isolates as having heightened virulence potential compared with other E. coli types in causing invasive infections, suggesting instead that ST131's epidemiological success may reflect an enhanced fitness for upstream steps in pathogenesis, including possibly colonization and transmission. Additionally, the observed extensive within-ST virulence variation suggests an op- portunity to compare closely related strains to identify the responsible genetic determinants.
